Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer

on behalf of the International Immuno-Oncology Biomarker Working Group on Breast Cancer

Resultado de la investigación: Contribución a una revistaArtículo de revisiónrevisión exhaustiva

187 Citas (Scopus)

Huella

Profundice en los temas de investigación de 'Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer'. En conjunto forman una huella única.

Medicina y ciencias biológicas